Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Fennec Pharmaceuticals Inc

FRX
Current price
6.1 CAD -0.08 CAD (-1.29%)
Last closed 5.92 CAD
ISIN CA31447P1009
Sector Healthcare
Industry Biotechnology
Exchange Toronto Exchange
Capitalization 165 315 673 CAD
Yield for 12 month -98.87 %
1Y
3Y
5Y
10Y
15Y
FRX
21.11.2021 - 28.11.2021

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. Address: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

131.6 CAD

P/E ratio

59.8

Dividend Yield

Current Year

+29 890 470 CAD

Last Year

+2 158 944 CAD

Current Quarter

+10 213 843 CAD

Last Quarter

+35 692 192 CAD

Current Year

+28 119 715 CAD

Last Year

+2 037 987 CAD

Current Quarter

+9 358 705 CAD

Last Quarter

+34 918 629 CAD

Key Figures FRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -13 142 332 CAD
Operating Margin TTM -69.39 %
PE Ratio 59.8
Return On Assets TTM 8.88 %
PEG Ratio
Return On Equity TTM -1005.59 %
Wall Street Target Price 131.6 CAD
Revenue TTM 49 390 072 CAD
Book Value -0.051 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 118.4 %
Dividend Yield
Gross Profit TTM 1 463 851 CAD
Earnings per share 0.1 CAD
Diluted Eps TTM 0.1 CAD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin 5.59 %

Dividend Analytics FRX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History FRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:3
Payout Ratio
Last Split Date 05.09.2014
Dividend Date

Stock Valuation FRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 59.8
Forward PE 9.7087
Enterprise Value Revenue 2.1831
Price Sales TTM 3.316
Enterprise Value EBITDA 16.2102
Price Book MRQ 57.9796

Financials FRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators FRX

For 52 weeks

5.76 CAD 15.59 CAD
50 Day MA 6.66 CAD
Shares Short Prior Month 75 282
200 Day MA 10.01 CAD
Short Ratio 24.17
Shares Short 76 636
Short Percent 0.41 %